Composition:
Active substances: benzocaine, bismuth subgallate, zinc oxide, menthol;
1 suppository contains benzocaine (0.1 g) 100 mg, bismuth subgallate (0.04 g) 40 mg, zinc oxide (0.02 g) 20 mg, menthol (0.004 g) 4 mg;
auxiliary substances: polyethylene oxide 1500, polyethylene oxide 400.
Medicinal form.
Suppositories.
Main physicochemical properties: greenish-yellow suppositories, bullet-shaped.
Pharmacotherapeutic group.
Means for the treatment of hemorrhoids and anal fissures for local use. local anesthetics. PBX code c05a d.
Pharmacological properties.
Pharmacodynamics.
Anaesthesolum is a complex drug, the therapeutic effect of which is determined by the pharmacological properties of the active components included in its composition. Anaesthesolum has a local anesthetic, anti-inflammatory and astringent effect.
Pharmacokinetics.
Was not studied.
Clinical characteristics.
Indication.
Symptomatic therapy of hemorrhoids and anal fissures.
Contraindication.
Increased sensitivity to the components of the drug. increased sensitivity to other amide anesthetics.
Interaction with other medicinal products and other types of interactions.
Was not studied.
Features of application.
With long-term use of the drug, control of blood parameters is necessary.
Use during pregnancy or breastfeeding.
For women during pregnancy or breastfeeding, the drug is prescribed by a doctor, taking into account the risk / benefit ratio.
The ability to influence the speed of reaction when driving vehicles or other mechanisms.
During treatment with the drug, it is recommended to refrain from driving vehicles and performing work that requires increased attention and precise coordination.
Method of application and dosage.
Before using the suppository, you must:
- tear off one suppository in the primary packaging along the perforation line of the blister pack;
- then it is necessary to pull the edges of the film, tearing it in different directions, and release the suppository from the primary packaging.
The drug is used rectally. 1 suppository 1-2 times a day after a bowel cleansing enema or independent defecation.
The duration of treatment is determined by the doctor, taking into account the course and severity of the disease, the achieved therapeutic effect.
Children.
There are no data on the use of the drug in children.
Overdose.
When used in therapeutic doses, overdose is unlikely. it is possible to increase the manifestations of adverse reactions. treatment is symptomatic.
Adverse reactions.
Sometimes allergic reactions, skin rash, itching occur. the drug can have a laxative effect, cause burning in the anus. with long-term use, blood reactions (methemoglobinemia) may develop.
Expiration date.
3 years.
Storage conditions.
Store at a temperature not higher than 25 °C.
Keep out of the reach of children.
Packaging.
5 suppositories in a blister, 1 or 2 blisters in a pack.
Prescription status.
Without a prescription.
Reviews
There are no reviews yet.